ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced myeloma: pfizer launches early trial
Disease control Not yet recruitingThis early-phase study tests a new drug, PF-07994525, in 120 adults with advanced multiple myeloma that has returned or not responded to treatment. The goal is to find a safe dose and see if the drug can shrink tumors. Researchers will closely monitor side effects and how the bod…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 07:02 UTC
-
New hope for advanced cancer patients as experimental drug enters human trials
Disease control Not yet recruitingThis early-stage trial tests an experimental drug called RP-001 in 66 adults with advanced solid tumors, including colorectal and pancreatic cancers. The main goal is to check the drug's safety and find the best dose. Researchers will also look for signs that the drug shrinks tum…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Recurv Pharma Inc • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New study checks cancer Drug's effect on common medications
Knowledge-focused Not yet recruitingThis study looks at how a cancer drug called pelabresib changes the way the body processes other drugs. It involves 24 adults with advanced cancers who have no standard treatment options. Participants will take pelabresib along with other medicines to measure drug levels in the b…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 18, 2026 12:07 UTC